$QNME

Quanome Technologies, Inc.

0
2
0

No SEC Form 4 filings for $QNME in the last 30 days.

See all $QNME insider activity →
Low

Quanome Technologies, Inc. (QNME): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Quanome Technologies, Inc. (QNME) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Resignation of Director On September 21, 2026, the Board of Directors (the “Board”) of Quanome Technologies, Inc. (the “Com

Quanome Technologies, Inc. (QNME): Entry into a Material Definitive Agreement

Quanome Technologies, Inc. (QNME) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Purchase and Sale Agreement On September 16, 2026, Quanome Technologies, Inc. (the “Company”) entered into a Purchase and Sale Agreement and related purchase order (collectively, the “Purchase Agreement”) with Compal Electroni

Lakeside Holding Ltd (LSH): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Lakeside Holding Ltd (LSH) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. false 0001996192 0001996192 2026-06-02 2026-06-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date

QNME sentiment & insider activity

Over the past 7 days, AlphAI's AI scored 2 news stories mentioning QNME (Quanome Technologies, Inc.). Coverage has been balanced: 0 bullish, 2 neutral, and 0 bearish.

Recent QNME coverage spans corporate actions and financial news.

What's driving QNME

  • Board change may affect governance perception but no immediate financial impact.

    SEC EDGAR 8-K · Sep 21, 2026

  • The agreement expands Quanome's hardware capacity for AI services.

    SEC EDGAR 8-K · Sep 21, 2026

  • Lakeside Holding Ltd (LSH) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. false 0001996192 0001996192 2026-06-02 2026-06-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date

    SEC EDGAR 8-K · Jun 5, 2026

  • Lakeside Holding Limited (LSH) is a U.S.-based cross-border supply chain firm with operations expanding into pharmaceutical distribution in China through its subsidiary Hupan Pharmaceutical. The company recently reported a decline in Q3 fiscal 2025 revenues to $3.80M from $4.46M year-over-year, alongside a net loss of $1.07M. Key strategic moves include a successful IPO, the acquisition of Hupan Pharmaceutical, and a $4.5M convertible debt financing agreement to diversify revenue streams.

    Stock Titan · May 12, 2026

  • Brink Holding Limited and its owner, Huifen Hua, have reported a beneficial ownership of 2,039,670 shares in Lakeside Holding Ltd (NASDAQ: LSH), representing an 8.569% stake. This information was disclosed in an amended Schedule 13G/A SEC filing, signed by Huifen Hua on May 4, 2026. The filing indicates that Brink Holding, wholly owned by Huifen Hua, has sole voting and dispositive power over these shares.

    Stock Titan · May 5, 2026

AlphAI scores every news story that mentions QNME with an AI model for sentiment and relevance, and aggregates insider trades from Quanome Technologies, Inc.'s SEC EDGAR Form 4 filings. Figures refresh continuously.

News on $QNME

Score
$QNMELow

Quanome Technologies, Inc. (QNME): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Quanome Technologies, Inc. (QNME) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers. Resignation of Director On September 21, 2026, the Board of Directors (the “Board”) of Quanome Technologies, Inc. (the “Com

$QNMEMed

Quanome Technologies, Inc. (QNME): Entry into a Material Definitive Agreement

Quanome Technologies, Inc. (QNME) filed an SEC Form 8-K — Entry into a Material Definitive Agreement. Item 1.01 Entry into a Material Definitive Agreement. Purchase and Sale Agreement On September 16, 2026, Quanome Technologies, Inc. (the “Company”) entered into a Purchase and Sale Agreement and related purchase order (collectively, the “Purchase Agreement”) with Compal Electroni

Lakeside Holding Ltd (LSH): Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers

Lakeside Holding Ltd (LSH) filed an SEC Form 8-K — Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers. false 0001996192 0001996192 2026-06-02 2026-06-02 iso4217:USD xbrli:shares iso4217:USD xbrli:shares UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or Section 15(d) of the Securities Exchange Act of 1934 Date

$LSHLow

Latest LSH News - Lakeside Announces Fiscal 2025 Third Quarter...

Lakeside Holding Limited (LSH) is a U.S.-based cross-border supply chain firm with operations expanding into pharmaceutical distribution in China through its subsidiary Hupan Pharmaceutical. The company recently reported a decline in Q3 fiscal 2025 revenues to $3.80M from $4.46M year-over-year, alongside a net loss of $1.07M. Key strategic moves include a successful IPO, the acquisition of Hupan Pharmaceutical, and a $4.5M convertible debt financing agreement to diversify revenue streams.

$LSHLow

Brink Holding and Huifen Hua report 8.569% stake in Lakeside (NASDAQ: LSH)

Brink Holding Limited and its owner, Huifen Hua, have reported a beneficial ownership of 2,039,670 shares in Lakeside Holding Ltd (NASDAQ: LSH), representing an 8.569% stake. This information was disclosed in an amended Schedule 13G/A SEC filing, signed by Huifen Hua on May 4, 2026. The filing indicates that Brink Holding, wholly owned by Huifen Hua, has sole voting and dispositive power over these shares.

Related tickers